AI-powered skin imaging analysis for clinical trials and dermatology research
SCARLETRED builds medical device software for standardized skin monitoring across clinical trials, biotech R&D, and post-market surveillance. The tech stack is mobile-first (Swift/iOS, Android, ARKit) paired with backend services in Java, C#, and Python—a shape consistent with regulated medical imaging where device certification and data handling dominate. Active pain points around modernizing legacy software and accelerating development cycles against compliance constraints reflect the operational tension typical of medtech: shipping faster while maintaining ICH-GCP and EU-GDPR certification.
SCARLETRED develops Scarletred® Vision, a certified mobile medical device platform for objective skin image analysis. The software serves biopharma, biotech, cosmetics, and clinical research organizations, replacing subjective visual assessment in pre-clinical, clinical, and post-marketing dermatology studies. The platform operates as SaaS, supporting both on-site and home-based monitoring with location-independent infrastructure. Founded in 2014 and headquartered in Vienna, the company employs 11–50 people with an engineering-heavy staffing model (6 of 8 current open roles), indicating ongoing product and infrastructure work. Hiring is currently decelerating and concentrated in Austria.
Mobile (Swift, iOS, Android, ARKit); backend (Java, C#, Python); data (MySQL, PostgreSQL, SQL Server); web (Angular, React, TypeScript, Laravel). GCP for infrastructure. Git for version control.
Mobile applications for patient and doctor-facing use cases, and digital capability expansion for Scarletred® Vision and Scarletred® Telemedicine platforms.
Other companies in the same industry, closest in size